Free Trial

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Given Average Recommendation of "Moderate Buy" by Analysts

Reckitt Benckiser Group logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Reckitt Benckiser Group PLC has an average analyst recommendation of “Moderate Buy” based on eight firms (1 sell, 3 hold, 2 buy, 2 strong buy).
  • Analyst views are mixed with recent notable moves: RBC downgraded to sector perform, Morgan Stanley upgraded to overweight, Citigroup initiated coverage with a buy, and Zacks cut to a strong sell.
  • Shares opened at $13.65, trading below the 50‑day ($15.38) and 200‑day ($15.71) moving averages with a 1‑year range of $12.73–$17.80; the company shows a debt-to-equity of 0.98 and a current ratio of 0.85.
  • Five stocks we like better than Reckitt Benckiser Group.

Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and two have issued a strong buy rating on the company.

Several analysts have issued reports on the company. Royal Bank Of Canada downgraded Reckitt Benckiser Group from an "outperform" rating to a "sector perform" rating in a research note on Wednesday, January 14th. Jefferies Financial Group reaffirmed a "hold" rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Morgan Stanley raised Reckitt Benckiser Group from an "equal weight" rating to an "overweight" rating in a research report on Monday, March 16th. Citigroup assumed coverage on Reckitt Benckiser Group in a research report on Wednesday, January 14th. They issued a "buy" rating on the stock. Finally, Zacks Research downgraded Reckitt Benckiser Group from a "hold" rating to a "strong sell" rating in a research report on Tuesday, April 7th.

Read Our Latest Research Report on RBGLY

Reckitt Benckiser Group Stock Performance

RBGLY opened at $13.65 on Thursday. The business's 50-day moving average price is $15.38 and its two-hundred day moving average price is $15.71. Reckitt Benckiser Group has a 1 year low of $12.73 and a 1 year high of $17.80. The company has a debt-to-equity ratio of 0.98, a current ratio of 0.85 and a quick ratio of 0.63.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

Further Reading

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines